Extracellular Vesicle Characterization Methods | EXIT071

Which extracellular vesicle (EV) characterization method is best? This article explores the strengths and limitations of current EV characterization technologies and discusses how to select complementary analytical approaches suited to your research goals in accordance with MISEV2023 recommendations.

Explore the EV characterization landscape, from NTA to high-resolution flow cytometry, and learn how to select the best approach in line with MISEV2023.

EV Characterization Methods: Choosing The Right Approach for Robust Research

Extracellular vesicles (EVs) are important mediators of intercellular communication and hold considerable promise for diagnostic and therapeutic applications. However, accurately characterizing EVs remains challenging. Current isolation methods are not perfectly selective and often co-isolate non-vesicular extracellular particles (NVEPs). Combined with the intrinsic heterogeneity and nanoscale dimensions of EVs, this makes establishing EV identity and sample composition technically demanding.

Robust EV characterization therefore relies on integrating multiple analytical techniques that probe complementary physical and biochemical properties of a sample. Regardless of the experimental question, researchers require information on particle abundance, size distribution, morphology, molecular composition, or sample purity.

This article provides an overview of the major EV characterization methods currently available and discusses how to select appropriate approaches for different research applications in line with MISEV2023 recommendations.

Key takeaways

  • Method selection is circumstantial: The optimal technique depends on the biological question, the sample type, and the property being measured.
  • Orthogonal approaches remain essential: Robust characterization typically combines complementary techniques for particle sizing, abundance measurements, molecular profiling, and purity assessment.
  • Single-particle technologies are expanding capabilities: Emerging methods such as SP-IRIS and Nano-FCM enable high-resolution phenotyping and subpopulation analysis at the single-vesicle level.

What EV characterization methods are available?

No single analytical technique captures all EV properties simultaneously. Consequently, EV characterization generally relies on a combination of orthogonal approaches that can be broadly grouped into bulk (ensemble) and single-particle techniques.

Bulk (Ensemble) Techniques

Bulk techniques measure the average signal from an EV population. They are often efficient and informative for quality control and molecular profiling but generally do not resolve the heterogeneity of individual vesicles.

TechniquePrimary Applications
Dynamic Light Scattering (DLS)Estimates average hydrodynamic size and sample polydispersity from fluctuations in scattered light intensity.
Western Blot / ELISAEvaluates EV-associated proteins and assesses the presence of common contaminants.
Mass Spectrometry (MS) / LC-MSGlobal or targeted profiling of EV proteins and lipids.
RNA-SeqComprehensive analysis of EV-associated RNA species, including miRNAs and other small RNAs.

Single-Particle Techniques

Single-particle methods interrogate individual vesicles or nanoparticles, enabling researchers to resolve population heterogeneity and identify distinct subpopulations.

TechniquePrimary Applications
Nanoparticle Tracking Analysis (NTA)Measures particle size distributions and particle concentrations using Brownian motion tracking.
Tuneable Resistance Pulse Sensing (TRPS)Measures particle size and concentration using changes in ionic current as particles pass through a nanopore.
Nano-flow cytometry (Nano-FCM)Enables particle sizing, concentration measurements, and fluorescence-based surface phenotyping.
TEM/Cryo-EMVisualizes particle morphology and membrane structure at nanometer resolution.
Atomic Force Microscopy (AFM)Provides topographical imaging and nanomechanical characterization of individual particles.
Single-Particle Interferometric Reflection Imaging Sensor (SP-IRIS)Combines immunocapture, interferometric imaging, and fluorescence detection for single-particle phenotyping of EV subpopulations.

How to select the best EV characterization methods?

Selecting an EV characterization method requires balancing sensitivity, specificity and throughput, while addressing the specific biological question. No technology is universally optimal, and each method has strengths and limitations.

1. Size Distribution and Abundance

Measuring the size distribution and abundance of EV preparations is approached through a variety of techniques, with each utilizing distinct physical principles.

  • NTA remains one of the most widely used approaches for measuring particle size distributions and concentrations in polydisperse samples. However, it is compositionally agnostic and cannot distinguish EVs from similarly sized NVEPs.
  • DLS is a rapid ensemble technique that performs best with relatively homogeneous samples. Measurements can be strongly influenced by larger particles and aggregates.
  • TRPS (RPS) provides high-resolution size and concentration measurements and can perform well in complex biofluids. Its measurements often show good agreement with electron microscopy, although, like other physical techniques, it measures all particles that pass through the nanopore.
  • Nano-FCM extends conventional flow cytometry to smaller particles and enables simultaneous fluorescence-based phenotyping, offering a bridge between physical characterization and molecular analysis.

2. Biomolecular Profiling and Phenotyping

Molecular heterogeneity is increasingly explored through immunocapture and single-particle phenotyping approaches.

  • ELISA provides high-throughput detection of specific EV-associated proteins.
  • SP-IRIS extends affinity capture to the single-particle level, enabling multiplexed surface-marker analysis and co-localization studies on captured EV populations.
  • Nano-FCM supports high-throughput phenotyping of fluorescently labelled particles in suspension.
  • Mass spectrometry and RNA sequencing remain important discovery tools for proteomic, lipidomic, and transcriptomic profiling.

3. Morphology & Purity Assessment

Structural characterization and purity assessment remain important components of EV validation.

  • Western Blotting is widely used to evaluate EV-associated proteins and assess common contaminants, particularly when used alongside complementary techniques.
  • TEM and Cryo-EM provide high-resolution visualization of EV morphology. Cryo-EM preserves particles in a near-native hydrated state and minimizes preparation artefacts associated with conventional TEM.
  • AFM offers label-free topographical imaging and can additionally probe nanomechanical properties such as stiffness and elasticity, which may provide complementary information about particle populations.

Ultimately, the most informative EV characterization workflows combine multiple orthogonal methods. By integrating physical, molecular, and structural measurements, researchers can build a more comprehensive and reliable picture of EV identity, composition, and heterogeneity.

Expert Perspective:

“Reliable EV characterization increasingly depends on integrating complementary analytical approaches. Because EV preparations are heterogeneous and current isolation methods are not perfectly selective, researchers often combine physical, molecular, and structural measurements to strengthen confidence in EV identity and sample composition.

At EXIT071, we use the Leprechaun platform for our internal EV characterization workflows. By integrating immunoaffinity capture, fluorescence detection, and SP-IRIS within a semi-automated system, Leprechaun consolidates particle size, abundance, and phenotypic measurements into a unified workflow. This multi-dimensional approach supports streamlined characterization, reproducible measurements, and the analysis of distinct EV subpopulations.”

FAQ:

How does the nature of the sample affect characterization workflow?

The characterization workflow and resulting data are strongly influenced by both the nature of the sample and the isolation method employed.

Different sample types contain distinct contaminants that can interfere with EV measurements. For example, urine samples often contain abundant uromodulin (Tamm–Horsfall protein), whereas plasma and serum samples are rich in lipoproteins. Consequently, purity controls should be selected according to the specific sample matrix.

The isolation strategy itself also impacts downstream characterization. Isolation methods often involve trade-offs between yield and purity and may favourably enrich specific EV populations based on their physical or biochemical properties. For example, size exclusion chromatography (SEC), ultracentrifugation (UC), and affinity-based enrichment methods each produce EV preparations with different compositions and analytical outcomes.

Is there a single best EV characterization method?

No. Each characterization method measures a different aspect of EV biology and comes with its own set of strengths and limitations.

Physical techniques such as NTA and TRPS provide information on particle size and abundance, whereas molecular assays such as Western blotting, mass spectrometry, and RNA sequencing probe biochemical composition. Imaging techniques such as TEM, Cryo-EM, and AFM provide structural information, while emerging single-particle technologies such as Nano-FCM and SP-IRIS enable detailed characterization of EV subpopulations.

Consequently, there is no one-size-fits-all approach, and the choice of characterization method ultimately depends on the specific research question and project requirements.

Conclusion:

The EV characterization landscape is diverse and rapidly evolving. No single technique currently provides a complete picture of EV identity, composition, and function. Instead, each method offers a distinct perspective, whether measuring particle abundance, size distribution, molecular composition, morphology, or phenotypic heterogeneity.

As a result, robust EV characterization increasingly relies on orthogonal workflows that integrate complementary physical, biochemical, and structural measurements. In line with MISEV2023, the goal is not to identify a universally “best” technology, but to generate evidence that is appropriate for the biological claim being made. By understanding the strengths and limitations of available approaches, researchers can design characterization workflows that are more transparent, reproducible, and informative.

Want to find out more about what our characterization services can offer?

Rosalba, PhD, is Project Lead at EXIT071, where she leads immuno-capture assay development and exosome analysis, guiding partner projects from concept to validation.

CAREERS

View all available positions to join the team!

PROJECT: ALIVE

Analytical platform for non-invasive diagnosis of liver disease